BioSpace News Archive

The Global Initiative on Sharing All Influenza Data (GISAID), a non-profit organization and public-private partnership dedicated to strengthening the world’s defense against deadly influenza threats, today welcomed a €250,000 donation from Seqirus, a leading innovator in influenza vaccine technologies and pandemic response solutions.

Consolidated financial results for the quarter ended June 30, 2018 under International Financial Reporting Standards

Batu Biologics announced today filing of a patent covering methods of matching cancer patients with experimental drugs under the new Right to Try Law. The recently passed law allows for companies that have passed Phase I of clinical trial to start offering terminal patients access to drugs that are still in development.

RadioMedix Inc. and ITM Isotopen Technologien München (ITM) announced today that ITM’s subsidiary, Isotope Technologies Garching GmbH (ITG), and RadioMedix have signed a manufacturing and supply agreement for the production of the next generation of Ge-68/Ga-68

The Canadian Institutes of Health Research launches competition to fund research that aims to treat, prevent PTSI in those who keep our communities safe

Hemophilia Federation of America will recognize 25 years serving the bleeding disorders community in 2019 with plans to display historical records at its annual symposium in San Diego.

Telmediq released details about healthcare’s only mobile-supported verbal order system.

Sutro Biopharma, Inc., has secured $85.4 million in Series E financing to advance its wholly-owned pipeline of novel cancer therapeutics, including two internally-developed antibody drug conjugates, or ADCs, known as STRO-001, now in Phase 1 clinical testing for lymphoma and multiple myeloma, and STRO-002, which is expected to enter clinical trials for ovarian and endometrial cancer by early 2019.

Expanded agreement with IBM Services to improve healthcare experience for nearly 40-million consumers

Perrigo Company plc announced that it will release its second quarter calendar year 2018 financial results on Thursday, August 9, 2018.